277 related articles for article (PubMed ID: 29548985)
1. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
2. N-trimethyl chitosan coated nano-complexes enhance the oral bioavailability and chemotherapeutic effects of gemcitabine.
Chen G; Svirskis D; Lu W; Ying M; Li H; Liu M; Wen J
Carbohydr Polym; 2021 Dec; 273():118592. PubMed ID: 34560993
[TBL] [Abstract][Full Text] [Related]
3. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
4. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
Ke Z; Guo H; Zhu X; Jin Y; Huang Y
J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
[TBL] [Abstract][Full Text] [Related]
5. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
6. Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles.
Zhang J; Zhu X; Jin Y; Shan W; Huang Y
Mol Pharm; 2014 May; 11(5):1520-32. PubMed ID: 24673570
[TBL] [Abstract][Full Text] [Related]
7. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
8. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
Joshi G; Kumar A; Sawant K
Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
[TBL] [Abstract][Full Text] [Related]
9. Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin.
Zhang P; Xu Y; Zhu X; Huang Y
Int J Pharm; 2015 Dec; 496(2):993-1005. PubMed ID: 26541299
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Enhanced Oral Absorption of a Nano-Drug Delivery System Loaded with Trimethyl Chitosan Derivatives.
Zhao Y; Lin S; Fang R; Shi Y; Wu W; Zhang W; Chen H
Int J Nanomedicine; 2022; 17():3313-3324. PubMed ID: 35937081
[TBL] [Abstract][Full Text] [Related]
11. Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.
Chen WL; Yuan ZQ; Liu Y; Yang SD; Zhang CG; Li JZ; Zhu WJ; Li F; Zhou XF; Lin YM; Zhang XN
Int J Nanomedicine; 2016; 11():325-36. PubMed ID: 26855571
[TBL] [Abstract][Full Text] [Related]
12. N-trimethyl chitosan coated targeting nanoparticles improve the oral bioavailability and antioxidant activity of vitexin.
Li S; Lv H; Chen Y; Song H; Zhang Y; Wang S; Luo L; Guan X
Carbohydr Polym; 2022 Jun; 286():119273. PubMed ID: 35337500
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
[TBL] [Abstract][Full Text] [Related]
14. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
[TBL] [Abstract][Full Text] [Related]
16. Role of chitosan nanoparticles in the oral absorption of Gemcitabine.
Derakhshandeh K; Fathi S
Int J Pharm; 2012 Nov; 437(1-2):172-7. PubMed ID: 22909993
[TBL] [Abstract][Full Text] [Related]
17. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery.
Du Q; Chen J; Yan G; Lyu F; Huang J; Ren J; Di L
Int J Pharm; 2019 Sep; 568():118506. PubMed ID: 31302169
[TBL] [Abstract][Full Text] [Related]
19. The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles.
Li X; Wang C; Liang R; Sun F; Shi Y; Wang A; Liu W; Sun K; Li Y
Pharm Res; 2015 Mar; 32(3):1017-27. PubMed ID: 25270570
[TBL] [Abstract][Full Text] [Related]
20. Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers.
Guan M; Zhu QL; Liu Y; Bei YY; Gu ZL; Zhang XN; Zhang Q
Int J Nanomedicine; 2012; 7():1921-30. PubMed ID: 22605938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
